Bloodstream Infection and Risk for Plasma Cell Neoplasms: A Population‐Based Cohort Study
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.70110 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Adam G Stewart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital, Bost…. Hauptthemen laut MEDLINE: Neoplasms, Plasma Cell, Bacteremia. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Invasive infection may be the first prompt to investigate the occult presence of a plasma cell neoplasm. The objective of this study was to quantify the risk for subsequent diagnosis of a plasma cell neoplasm following bloodstream infection (BSI).
Methods
Statewide population‐based surveillance was conducted from January 1 2000 – December 31 2019. Statewide databases were used to identify patients with incident plasma cell neoplasms diagnosed within 1‐year following a BSI diagnosis.
Results
A cohort of 90 individuals who had BSI within the year preceding diagnosis of plasma cell neoplasm and 95 753 patients with BSI without this malignancy were included. The time to diagnose a plasma cell neoplasm was a median 123 (31–221) days after index BSI. The overall incidence of plasma cell neoplasms among those with incident BSI was 93.9 per 100 000 population annually. Among the study population, development of a BSI was associated with a 13‐fold increased risk for diagnosis of plasma cell neoplasm (IRR; 12.9; 95% CI, 10.3–15.8; p < 0.001). The increased risk following BSI was elevated for both sexes, with a magnitude of risk higher for females (IRR; 14.0; 95% CI, 9.8–19.4). Streptococcus pneumoniae BSI was associated with the highest risk for subsequent diagnosis of a plasma cell neoplasm (IRR 46.9; 95% CI; 26.2–77.4).
Conclusions
The presence of a BSI, particularly with S. pneumoniae , is a marker for occult plasma cell neoplasms in a small but significant number of patients. Further studies are warranted to identify occult neoplastic disease investigation strategies for patients with incident BSIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Faculty of Medicine, UQ Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia.
- Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
- Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
ORCID-Profile: Adam G Stewart
Zitieren
APA
Stewart, A. G., Edwards, F., & Laupland, K. B. (2025). Bloodstream Infection and Risk for Plasma Cell Neoplasms: A Population‐Based Cohort Study. Transplant Infectious Disease. https://doi.org/10.1111/tid.70110
Vancouver
Stewart AG, Edwards F, Laupland KB. Bloodstream Infection and Risk for Plasma Cell Neoplasms: A Population‐Based Cohort Study. Transplant Infectious Disease. 2025. doi:10.1111/tid.70110
BibTeX
@article{Stewart2025,
author = {Stewart, Adam G and Edwards, Felicity and Laupland, Kevin B},
title = {Bloodstream Infection and Risk for Plasma Cell Neoplasms: A Population‐Based Cohort Study},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.70110}
}
EUVIMED